New drugs approved for use in Scottish NHS

The Scottish Medicines Consortium (SMC) has accepted the following new drugs for use within NHS Scotland:

  • Rotigotine (Neupro) for the symptomatic treatment of moderate to severe idiopathic restless legs syndrome in adults.
  • Etravirine (Intelence) for use in combination with a boosted protease inhibitor and other antiretroviral agents, to treat HIV-1 infection in antiretroviral-experienced adults.
  • Histrelin (Vantas) subcutaneous implant for restricted use in the palliative treatment of advanced prostate cancer.
  • Calcipotriol and betamethasone dipropionate scalp gel (Xamiol) for the topical treatment of scalp psoriasis.
  • Peginterferon alfa-2a (Pegasys) for use in combination with ribavirin to treat chronic hepatitis C in adults.

The SMC rejected degarelix (Firmagon) for the treatment of men with advanced hormone-dependent prostate cancer.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Added: fludroxycortide, levofloxacin, Noriday, Ongentys...

Vaping still safer than smoking, say health bosses after report of severe lung injury
Free online vestibular rehabilitation tool 'highly effective' for vertigo symptoms

Free online vestibular rehabilitation tool 'highly effective' for vertigo symptoms

GPs should consider online vestibular rehabilitation...

Thiazides better than ACE inhibitors as first-line antihypertensives, large-scale analysis suggests